PD-1/PDL-1 (PROGRAMMED CELL DEATH PROTEIN 1/DEATH LIGAND 1) INHIBITORS
- atezolizumab (TECENTRIQ, TECENTRIQ SC)
- avelumab (BAVENCIO)
- cemiplimab (LIBTAYO)
- dostarlimab (JEMPERLI)
- durvalumab (IMFINZI)
- nivolumab (OPDIVO SC, OPDIVO)
- pembrolizumab (KEYTRUDA, KEYTRUDA SC)
- retifanlimab (ZYNYZ)
- toripalimab (LOQTORZI)
Using Health Canada Drug Database
updated on 11Apr2026.